Development of Cancer Immunoprevention Agents
This grant opportunity is for the development of therapeutic cancer vaccines and immunomodulatory drugs for cancer prevention and interception, especially for non-virus-caused cancers. It targets high-risk populations, such as those with genetic mutations, precancers, or exposure to carcinogens. The grant supports small businesses in translating preclinical findings into clinical applications.…
Fast-Track proposals will be accepted.\nDirect-to-Phase II proposals will be accepted.\nNumber of anticipated awards: 2-4\nBudget (total costs, per award):\nPhase I: up to $400,000 for up to 12 months\nPhase II: up to $2,250,000 for up to 2 years\nPROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURA…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers